1.
Khan L, Salsabil MA, Ferdous J, Haque MR. Evaluation of Myelosupression during Imatinib Mesylate Therapy in Patients with Chronic Myeloid Leukaemia. J. Armed Forces Med. Coll. [Internet]. 2020 Dec. 20 [cited 2022 Dec. 3];15(2):189-92. Available from: https://banglajol.info/index.php/JAFMC/article/view/50833